GIP: No Longer the Neglected Incretin Twin?

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Science Translational Medicine

• Publication date

  2010-09-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1126/scitranslmed.3001027PMID 20844284
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glucose Intolerance and Reduced Proliferation of Pancreatic β-Cells in Transgenic Pigs With Impaired Glucose-Dependent Insulinotropic Polypeptide Function

  2010cited by this paper
• A GIP Receptor Agonist Exhibits β-Cell Anti-Apoptotic Actions in Rat Models of Diabetes Resulting in Improved β-Cell Function and Glycemic Control

  2010cited by this paper
• Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge

  2010cited by this paper
• Therapeutic Potential of Aleglitazar, a New Dual PPAR-α/γ Agonist

  2010cited by this paper
• Glucagon-like Peptide-1 Increases β-Cell Glucose Competence and Proliferation by Translational Induction of Insulin-like Growth Factor-1 Receptor Expression*

  2010cited by this paper
• The pseudokinase tribbles homolog 3 interacts with ATF4 to negatively regulate insulin exocytosis in human and mouse beta cells.

  2010cited by this paper
• Missing heritability and strategies for finding the underlying causes of complex disease

  2010cited by this paper
• GIP increases human adipocyte LPL expression through CREB and TORC2-mediated trans-activation of the LPL gene

  2010cited by this paper
• Dual endothelin receptor antagonism prevents remodeling of resistance arteries in diabetes.

  2010cited by this paper
• Xenin-25 Potentiates Glucose-dependent Insulinotropic Polypeptide Action via a Novel Cholinergic Relay Mechanism*

  2010cited by this paper
• Genomewide association studies and human disease.

  2009cited by this paper
• Transgenerational genetic effects on phenotypic variation and disease risk.

  2009cited by this paper
• Role and development of GLP-1 receptor agonists in the management of diabetes

  2009cited by this paper
• Growth factor control of pancreatic islet regeneration and function

  2009cited by this paper
• Glucose-dependent insulinotropic polypeptide (Gastric Inhibitory Polypeptide; GIP).

  2009cited by this paper
• Therapeutic potential for GIP receptor agonists and antagonists.

  2009cited by this paper
• Insulin Action in the Double Incretin Receptor Knockout Mouse

  2008cited by this paper
• Physiology of incretins (GIP and GLP-1) and abnormalities in type 2 diabetes.

  2008cited by this paper
• RNA induction and inheritance of epigenetic cardiac hypertrophy in the mouse.

  2008cited by this paper
• Trans-generational epistasis between Dnd1Ter and other modifier genes controls susceptibility to testicular germ cell tumors.

  2007cited by this paper
• The role of gut hormones in glucose homeostasis.

  2007cited by this paper
• Exendin-4 Uses Irs2 Signaling to Mediate Pancreatic β Cell Growth and Function*

  2006cited by this paper
• Exendin-4 uses Irs2 signaling to mediate pancreatic beta cell growth and function.

  2006cited by this paper
• GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice.

  2005cited by this paper
• Glucose-dependent Insulinotropic Polypeptide (GIP) Stimulation of Pancreatic β-Cell Survival Is Dependent upon Phosphatidylinositol 3-Kinase (PI3K)/Protein Kinase B (PKB) Signaling, Inactivation of the Forkhead Transcription Factor Foxo1, and Down-regulation of bax Expression*

  2005cited by this paper
• GIP as a potential therapeutic agent?

  2004cited by this paper
• Double incretin receptor knockout (DIRKO) mice reveal an essential role for the enteroinsular axis in transducing the glucoregulatory actions of DPP-IV inhibitors.

  2004cited by this paper
• Gluco-incretins control insulin secretion at multiple levels as revealed in mice lacking GLP-1 and GIP receptors.

  2004cited by this paper
• GIP as a Potential Therapeutic Agent?

  2004cited by this paper
• Post-challenge hyperglycaemia is associated with premature death and macrovascular complications

  2003cited by this paper
• Glucose-dependent insulinotropic polypeptide receptor null mice exhibit compensatory changes in the enteroinsular axis.

  2003cited by this paper
• cAMP promotes pancreatic β-cell survival via CREB-mediated induction of IRS2

  2003cited by this paper
• cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2.

  2003cited by this paper
• Inhibition of gastric inhibitory polypeptide signaling prevents obesity

  2002cited by this paper
• Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice.

  1999cited by this paper
• Discovery of amino acid variants in the human glucose-dependent insulinotropic polypeptide (GIP) receptor: the impact on the pancreatic beta cell responses and functional expression studies in Chinese hamster fibroblast cells

  1998cited by this paper
• Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP). Effect of a specific glucose-dependent insulinotropic polypeptide receptor antagonist in the rat.

  1996cited by this paper
• Glucagon-like peptide-1 is a physiological incretin in rat.

  1995cited by this paper
• Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.

  1993cited by this paper
• Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas.

  1987cited by this paper
• Glucagon-like peptide-1 7-36: a physiological incretin in man.

  1987cited by this paper
• Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses.

  1986cited by this paper
• Identification and actions of gastric inhibitory polypeptide.

  1975cited by this paper
• NEW INTERPRETATION OF ORAL GLUCOSE TOLERANCE.

  1964cited by this paper
• Sur les possibilites d'un traitement du diabete par I'incretine

  1932cited by this paper
• On the causation of the so-called ‘peripheral reflex secretion’ of the pancreas. (Preliminary communication.)

  year unknowncited by this paper

• Digital Scholarship @ Texas Southern University Digital Scholarship @ Texas Southern University

  2022cites this paper
• Effects of mixed meal tolerance test on gastric emptying, glucose and lipid homeostasis in obese nonhuman primates

  2021cites this paper
• Circulating obesity-driven biomarkers are associated with risk of clear cell renal cell carcinoma: a two-stage, case-control study.

  2019cites this paper
• The effects of licogliflozin, a dual SGLT1/2 inhibitor, on body weight in obese patients with or without diabetes

  2019cites this paper
• Exploring inter-organ crosstalk to uncover mechanisms that regulate β-cell function and mass

  2017cites this paper
• Exendin-4, a glucagon-like peptide-1 analogue, accelerates diabetic wound healing.

  2017cites this paper
• Effects of Anesthesia on Hyperglycemic and Insulinotropic Responses to Intravenous Glucose and Mixed Meal Tolerance Tests in Cynomolgus Monkeys with Naturally Occurring Diabetes

  2017cites this paper
• Prediction of remission after metabolic surgery using a novel scoring system in type 2 diabetes – a retrospective cohort study

  2014cites this paper
• Role of the Glucagon and Glucagon-like Peptides in Pancreatic Beta Cell and Cardiovascular Function

  2014cites this paper
• Emerging combinatorial hormone therapies for the treatment of obesity and T2DM

  2013cites this paper
• Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans

  2013cites this paper
• Direct cardiovascular effects of glucagon like peptide-1

  2013cites this paper
• Glucagon-Like Peptide-1 and its Cardiovascular Effects

  2012cites this paper
• Novel role for the incretins in blood pressure regulation

  2012cites this paper
• First inducible transgene expression in porcine large animal models

  2012cites this paper
• Laparoscopic ileal interposition with diverted sleeve gastrectomy for treatment of type 2 diabetes.

  2012cites this paper
• Cardiovascular biology of the incretin system.

  2012influential citation
• Discovery of Dual-Action Membrane-Anchored Modulators of Incretin Receptors

  2011influential citation
• Dual-monoclonal, sandwich immunoassay specific for glucose-dependent insulinotropic peptide1-42, the active form of the incretin hormone.

  2011cites this paper
• Exendin-4, a glucagon-like peptide-1 receptor analogue, accelerates diabetic wound healing

  year unknowncites this paper